针对小细胞肺癌的杜尔瓦卢马布治疗后致命的免疫相关肺炎:中国首例病例
Qian Li1, Mei Liu2, Yunxia Liu1
1Qingdao Jiaozhou Central Hospital, Qingdao, PR China.
Case reports in oncology
|July 17, 2024
概括
编程死亡配体1 (PD-L1) 抑制剂与化疗相结合,可能导致致命的免疫相关肺炎. 早期诊断和干预对于接受这种癌症治疗的患者至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 编程死亡配体1 (PD-L1) 抑制剂与化疗相结合,代表了一种有前途的癌症治疗策略.
- 然而,这些疗法可以引发免疫相关的不良事件,包括肺炎.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.2K
